Elevated Capital Advisors LLC Sells 103 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Elevated Capital Advisors LLC lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,593 shares of the medical equipment provider’s stock after selling 103 shares during the quarter. Elevated Capital Advisors LLC’s holdings in Intuitive Surgical were worth $831,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors also recently added to or reduced their stakes in the business. Mirador Capital Partners LP raised its position in Intuitive Surgical by 1.4% during the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after purchasing an additional 50 shares during the last quarter. Exome Asset Management LLC lifted its stake in Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after acquiring an additional 1,069 shares during the period. Consolidated Planning Corp increased its position in Intuitive Surgical by 17.4% during the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after purchasing an additional 1,198 shares during the period. Wealth Enhancement Advisory Services LLC raised its holdings in Intuitive Surgical by 73.2% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 270,029 shares of the medical equipment provider’s stock worth $132,657,000 after purchasing an additional 114,149 shares in the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund lifted its position in shares of Intuitive Surgical by 617.1% in the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock worth $39,622,000 after purchasing an additional 76,649 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the company. Evercore ISI reiterated a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Citigroup lifted their target price on Intuitive Surgical from $567.00 to $640.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. Leerink Partners upped their price target on Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. Mizuho lifted their price objective on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Finally, Stifel Nicolaus upped their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, December 5th. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $554.17.

Intuitive Surgical Stock Down 1.4 %

ISRG traded down $7.72 on Monday, reaching $539.75. 1,387,774 shares of the company traded hands, compared to its average volume of 1,350,754. The company has a market cap of $192.25 billion, a P/E ratio of 86.78, a price-to-earnings-growth ratio of 5.31 and a beta of 1.39. The firm has a fifty day simple moving average of $535.93 and a two-hundred day simple moving average of $495.17. Intuitive Surgical, Inc. has a one year low of $355.17 and a one year high of $556.23.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The business had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Insider Activity at Intuitive Surgical

In other news, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Jamie Samath sold 270 shares of the business’s stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total transaction of $145,840.50. Following the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,730,093.55. This trade represents a 2.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 48,190 shares of company stock valued at $25,012,927 over the last 90 days. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.